rcuitry should result in effective therapies for even those OCD patients who are refractory to currently available treatments (e.g., Zoloft, Paxil, Anafranil, Prozac, etc.). While these studies of "core circuitry" and cell types altered in OCD are fundamental for progress in OCD treatment, it is clear tha